Literature DB >> 29077869

Dolutegravir-induced hyperglycaemia in a patient living with HIV.

Milena McLaughlin1,2, Sylvia Walsh3, Shannon Galvin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29077869     DOI： 10.1093/jac/dkx365

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

Review 1.  Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.

Authors:  Todd Hulgan
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 2.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

Review 3.  Metabolic Consequences of Antiretroviral Therapy.

Authors:  Caroline E Diggins; Samuel C Russo; Janet Lo
Journal:  Curr HIV/AIDS Rep       Date:  2022-03-17       Impact factor: 5.071

4.  Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.

Authors:  Nathan A Summers; Cecile D Lahiri; Christine D Angert; Amalia Aldredge; C Christina Mehta; Ighovwerha Ofotokun; Anne M Kerchberger; Deborah Gustafson; Sheri D Weiser; Seble Kassaye; Deborah Konkle-Parker; Anjali Sharma; Adaora A Adimora; Hector Bolivar; Jennifer Cocohoba; Audrey L French; Elizabeth T Golub; Anandi N Sheth
Journal:  J Acquir Immune Defic Syndr       Date:  2020-11-01       Impact factor: 3.771

5.  Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus.

Authors:  Nathanial S Nolan; Samantha Adamson; Dominic Reeds; Jane A O'Halloran
Journal:  Open Forum Infect Dis       Date:  2021-04-16       Impact factor: 3.835

6.  Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus.

Authors:  Agete Tadewos Hirigo; Selamawit Gutema; Aberash Eifa; Worku Ketema
Journal:  SAGE Open Med Case Rep       Date:  2022-02-23

Review 7.  HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.

Authors:  Kimberly K Scarsi; Joshua P Havens; Anthony T Podany; Sean N Avedissian; Courtney V Fletcher
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

Review 8.  Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment.

Authors:  Christine Bourgeois; Jennifer Gorwood; Anaelle Olivo; Laura Le Pelletier; Jacqueline Capeau; Olivier Lambotte; Véronique Béréziat; Claire Lagathu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

9.  Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study.

Authors:  Henry Zakumumpa; Freddy Eric Kitutu; Helen Byomire Ndagije; Nakitto-Kesi Diana; Jacquellyn Nambi Ssanyu; Ronald Kiguba
Journal:  BMC Infect Dis       Date:  2021-12-07       Impact factor: 3.090

10.  Hyperglycemia After Dolutegravir-Based Antiretroviral Therapy.

Authors:  Workagegnehu Hailu; Tsebaot Tesfaye; Abilo Tadesse
Journal:  Int Med Case Rep J       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.